Mexico Microfluidics Market Overview, 2029

Mexico Microfluidics Market Overview, 2029

Most of the success stories in the growth of the microfluidics market within Mexico originate from successful industry-academia collaborations. This case study presents a few of the critical projects and innovations that have placed Mexico at the frontline of the development of microfluidic technology. Indeed, the Mexican microfluidics market is surely a subset of a larger global ecosystem with enormous interactions and dependencies on international markets. A strong interaction with global players brings along a corresponding position in the international trade and research networks, which means new technologies, markets, and funding. At the same time, this globalization of the market implies that international standards and regulatory requirements are increasingly demanded, paving the road for building exports of Mexican microfluidic products. In the market for microfluidics, sustainability is becoming an increasingly important factor. Attention is being turned to the ecological footprint of the manufacturing and disposal of microfluidic devices, and companies are increasing their consideration toward eco-friendly materials and methods of production. The development of biodegradable and recyclable materials for microfluidic devices is an area of growing research. Apart from that, reduction in amount of energy consumed during the manufacturing process and waste generation are the major factors for a low ecological footprint of the industry. Emphasizing sustainability can further increase the marketability of microfluidic products since modern customers, as well as regulatory bodies, are gravitating toward eco-friendly solutions. Innovation is the keystone in the Mexican microfluidics market, with many companies and research institutions filing active patents to protect their technological advancements. According to the Mexican Institute of Industrial Property, the number of patents related to microfluidics has increased, which mirrors the high level of research and development activity in the country. Such patents so far include a huge portfolio of aspects that range from new materials and techniques of fabrication to novel applications and devices. This will enhance the protection of intellectual property and allow companies to reap competitive advantages, thereby attracting investment.

According to the research report ""Mexico Microfluidics Market Overview, 2029,"" published by Bonafide Research, the Mexico Microfluidics market is anticipated to add to more than USD 520 Million by 2024–29.Environmental and ethical considerations are fast becoming a significant factor in the microfluidics market. A large number of efforts are now being made toward developing sustainable materials for the production of microfluidic devices, as there is increasing pressure to reduce the ecological footprint of medical and laboratory equipment. On the other hand, ethical considerations like ensuring that microfluidic technologies will not be used for hostile purposes by researchers and in clinical settings should not be underestimated either. These considerations would be very important in keeping public trust and for the long-term sustainability of the microfluidic market in Mexico. Supply chain and the distribution network are two important aspects related to the microfluidic market. Effective supply chain management ensures timely availability of raw materials and components that go into manufacturing microfluidic devices. The companies have to build strong distribution channels for effectively covering their target markets. Partnerships with distributors and suppliers are very important for all times material supply and delivery of different products to customers efficiently. The competitive landscape that the microfluidics market in Mexico presents includes a mixture of established firms and start-ups, which are rather innovative in nature. Established players like PerkinElmer, Fluidigm Corporation, and Bio-Rad Laboratories dominate the market with their broad product portfolio and strong market presence.

The Mexico microfluidics market can be segmented into two product types including microfluidic-based devices and microfluidic components. Microfluidic-based Devices comprises complete systems that integrate the microfluidic technology to perform specific functions like diagnosis, testing, or analysis. Such devices would be wholly designed to offer a complete solution for a particular application and often contain several microfluidic components. In Mexico, microfluidic-based devices find applications in many industries—including healthcare, pharmaceuticals, and biotechnology. For instance, point-of-care testing devices are being widely accepted in the Mexican healthcare environment for the quick and correct diagnosis of diseases like diabetes, infectious diseases, and cancer. Furthermore, the Mexican research institutions and pharmaceutical companies apply microfluidic-based PCR systems to accelerate the discovery of new drugs and therapies. Moreover, LAB-CHIP devices are applied in Mexican biotechnology industries to develop new diagnostic tests and personalized medicines. On the contrary, microfluidic components are single parts of devices used to develop microfluidic-based devices. These are components that can be customized to develop microfluidic systems of interest or retrofitted into already existing devices. Mexico is another robust demand for microfluidic components, largely driven by health and pharmaceutical applications. For example, Mexican research institutions are already under way using microfluidic chips in the development of new infectious disease diagnostic tests, while pharmaceuticals firms use microfluidic pumps for new drug delivery systems. Besides this, microneedles are in use at Mexican biotechnology companies for developing the state-of-the-art transdermal drug delivery systems. Other microfluidic components, such as valves, sensors, and connectors, find applications in a number of industries in Mexico. This has consequently resulted in the development of various novel microfluidic-based devices and systems.

The growth in demand for point-of-care diagnostics, increasing research activities in the life sciences, and the urge for cost-effective, efficient analytical tools drive the Mexican microfluidics market. Microfluidic devices are used mostly in academic research and development dedicated to biology, chemistry, and engineering. There are many universities and research institutions in Mexico with active involvement in microfluidics-related research. For example, groups at the National Autonomous University of Mexico and at the Monterrey Institute of Technology and Higher Education work on microfluidics and their applications. The Mexican regime of healthcare is also not left out in utilizing this microfluidic device. With the increasing demand for rapid, accurate, and cost-effective diagnostic tools, microfluidic devices find a increasing usage in point-of-care diagnostics. For example, SISDIAGNOSTICS, a Mexican company, has developed a microfluidic device for HIV detection. Mexican microfluidics holds some potential in food and beverages. In the food and beverage industries in particular, this device can be utilized for several activities, such as food safety testing, quality control, and process optimization. For example, one of these Mexican companies is SENASICA, which means National Service for Health, Food Safety and Food Quality, using a microfluidic device with the view of food safety testing. Basically, because they are low-cost and biocompatible, polymers top the list of materials used for microfluidic devices from Mexico. With the use of this material, fabrication with channels becomes easy, allowing at the same time some kind of adaptation to specific uses. Glass and silicon are also employed where high-precision optical transparency is required.

The microfluidics market in Mexico is growing and diversifying into new fields of applications because the country represents an interesting mixture of healthcare needs, growing biotechnology, and numerous environmental challenges. In this respect, Mexican researchers and healthcare institutions turn to microfluidic technologies in the development of fast and portable diagnostic devices for diseases like dengue fever, which answers a urgent call for more accessible diagnostics outside of tertiary centers. The use of microfluidic platforms transforms even the pharmaceutical and biotechnological research landscape, with applications in institutions such as CINVESTAV for high-throughput drug screening that may increase the pace of finding new treatments more in keeping with the health profile of the Mexican population. In addition, the application of microfluidics in the field of in vitro diagnostics is innovated through companies like Microdetek in the face of antibiotic resistance, one of the pressing matters in health care across Mexican terrain. Beyond medical applications, a form of massive deployment of microfluidic technology is in environmental monitoring. Water quality sensors are being developed at IPICYT to respond to urgent concerns about pollution caused by urban centers and agriculture. This growth is multidimensional, powered by government initiatives, especially funding from CONACYT that supports collaboration between academia and industries and helps push the research into commercial applications. While a large manufacturing base already exists in Mexico, especially for medical devices, thereby providing an opportunity as to potential production location for microfluidic devices, low local expertise in advanced microfluidic technologies yet remains a constraint.

The Mexico microfluidics market caters to a variety of end-users, including hospitals and diagnostic centers, pharmaceutical and biotechnology companies, academic and research institutes, and others such as CROs and industrial users. Hospitals and diagnostic centers represent one of the major end-users of microfluidic devices in Mexico. There is a huge demand for rapid, accurate, cost-effective diagnostic tools, especially in these settings. Microfluidic devices provide several advantages, such as low sample volumes, high throughput, and portability, making them perfect for point-of-care diagnostics. For instance, SISDIAGNOSTICS from Mexico has developed a microfluidic device for the detection of HIV in use in hospitals and diagnostic centers. Some other main end-users of microfluidic devices in Mexico include pharmaceutical and biotechnological firms. Such companies apply microfluidic devices for drug discovery, drug development, and quality control. Of course, devices with a number of advantages make them very suitable for these applications. These have the benefits of high throughput screening, low sample volume requirements, and tight control over reaction conditions. For example, ProMab Biotechnologies, a Mexican company, applies microfluidic devices in antibody discovery and development. Academic and research institutes make up a very significant proportion of the end-users for microfluidic devices in Mexico. Such institutes, engaged in various fields like biology, chemistry, and engineering, utilize microfluidic devices for some research-oriented development processes. Microfluidic devices offer advantages such as control over reaction conditions with good precision, high throughput, and low sample volume requirements that make them ideally suited for research applications. For instance, groups at the National Autonomous University of Mexico and at the Monterrey Institute of Technology and Higher Education are working in microfluidics and their applications. Other end-users of microfluidic devices in Mexico are the CROs or industrial users. The former applies microfluidic devices in the drug discovery and developmental stages, while the latter applies them in process optimization and quality control. For example, Mexican company BioMimetic Pharmaceuticals applies microfluidic devices in the development of biomimetic materials.

Considered in this report
• Historic year: 2018
• Base year: 2023
• Estimated year: 2024
• Forecast year: 2029

Aspects covered in this report
• Microfluids market Outlook with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Microfluidic-based Devices
• Microfluidic Components (Microfluidic Chips, Micro Pumps, Microneedles and other Mocrofluids Components Type)

By Material
• Polymer
• Glass
• Silicon
• Other Materials (Paper-based microfluidics, Ceramic-based microfluidics, Hydrogels, Metal-based microfluidics)

By Application
• Point-of-care diagnostics
• Drug delivery systems
• Pharmaceutical and biotechnology research
• In vitro diagnostics
• Others (e.g., environmental testing, industrial applications)

By End User
• Hospitals and diagnostic centers
• Pharmaceutical and biotechnology companies
• Academic and research institutes
• Others (e.g., contract research organizations, industrial users)

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the Microfluids industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.